Page 169 - 2019_05-HaematologicaMondo-web

miRNA in Richter syndrome
ses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group. J Clin Oncol. 2009;27(24):3994- 4001.
17. Chigrinova E, Rinaldi A, Kwee I, et al. Two main genetic pathways lead to the transfor- mation of chronic lymphocytic leukemia to Richter syndrome. Blood. 2013;122(15): 2673-2682.
18. Bagnara D, Kaufman MS, Calissano C, et al. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood. 2011;117(20):5463-5472.
19. Chen SS, Chiorazzi N. Murine genetically engineered and human xenograft models of chronic lymphocytic leukemia. Semin Hematol. 2014;51(3):188-205.
20. Patten PE, Ferrer G, Chen SS, et al. Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1- dependent, Bcl-6-deficient process. JCI Insight. 2016;1(4).
21. Ferrajoli A, Ivan C, Ciccone M, et al. Epstein-Barr virus microRNAs are expressed in patients with chronic lympho- cytic leukemia and correlate with overall survival. EBioMedicine. 2015;2(6):572-582.
22. Vasilescu C, Dragomir M, Tanase M, et al. Circulating miRNAs in sepsis. A network under attack: an in-silico prediction of the potential existence of miRNA sponges in sepsis. PLoS One. 2017;12(8):e0183334.
23. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA- 21-induced pre-B-cell lymphoma. Nature. 2010;467(7311):86-90.
24. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101(9):2999-3004.
25. Sevignani C, Calin GA, Nnadi SC, et al. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A. 2007;104(19):8017- 8022.
26. Boi M, Rinaldi A, Kwee I, et al. PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood. 2013;122(15):2683-2693.
27. Martinez N, Almaraz C, Vaque JP, et al. Whole-exome sequencing in splenic mar- ginal zone lymphoma reveals mutations in genes involved in marginal zone differentia- tion. Leukemia. 2014;28(6):1334-1340.
28. Rinaldi A, Kwee I, Young KH, et al. Genome-wide high resolution DNA profil- ing of hairy cell leukaemia. Br J Haematol. 2013;162(4):566-569.
29. Rossi D, Trifonov V, Fangazio M, et al. The apoptosis. Exp Dermatol. 2012;21(4):312- coding genome of splenic marginal zone 314.
lymphoma: activation of NOTCH2 and 42. Wang S, Wan X, Ruan Q. The microRNA- other pathways regulating marginal zone 21 in autoimmune diseases. Int J Mol Sci. development. J Exp Med. 2012;209(9):1537- 2016;17(6).
1551. 43. Xu WD, Pan F, Li JH & Ye DQ. MicroRNA- 30. Van Roosbroeck K, Calin GA. MicroRNAs 21 with therapeutic potential in autoim- in chronic lymphocytic leukemia: miRacle mune diseases. Expert Opin Ther Targets.
or miRage for prognosis and targeted thera- 2013;17(6):659-665.
pies? Semin Oncol. 2016;43(2):209-214. 44. Curtale G, Mirolo M, Renzi TA, et al. 31. Chiorazzi N. Cell proliferation and death: Negative regulation of Toll-like receptor 4 forgotten features of chronic lymphocytic signaling by IL-10-dependent microRNA- leukemia B cells. Best Pract Res Clin 146b. Proc Natl Acad Sci U S A.
Haematol. 2007;20(3):399-413. 2013;110(28):11499-11504.
32. Rossi S, Shimizu M, Barbarotto E, et al. 45. Taganov KD, Boldin MP, Chang KJ, microRNA fingerprinting of CLL patients Baltimore D. NF-kappaB-dependent induc- with chromosome 17p deletion identify a tion of microRNA miR-146, an inhibitor tar- miR-21 score that stratifies early survival. geted to signaling proteins of innate Blood. 2010;116(6):945-952. immune responses. Proc Natl Acad Sci U S
33. Fulci V, Chiaretti S, Goldoni M, et al. A. 2006;103(33):12481-12486.
Quantitative technologies establish a novel 46. Bezman NA, Chakraborty T, Bender T, microRNA profile of chronic lymphocytic Lanier L L. miR-150 regulates the develop- leukemia. Blood. 2007;109(11):4944-4951. ment of NK and iNKT cells. J Exp Med.
34. Ferracin M, Zagatti B, Rizzotto L, et al. 2011;208(13):2717-2731.
MicroRNAs involvement in fludarabine 47. Sang W, Wang Y, Zhang C, et al. MiR-150 refractory chronic lymphocytic leukemia. impairs inflammatory cytokine production Mol Cancer. 2010;9:123. by targeting ARRB-2 after blocking
35. Szurian K, Csala I, Piurko V, et al. CD28/B7 costimulatory pathway. Immunol Quantitative miR analysis in chronic lym- Lett. 2016;172:1-10.
phocytic leukaemia/small lymphocytic 48. Wang Y, Mao G, Lv Y, Huang Q, Wang G. lymphoma - proliferation centres are char- MicroRNA-181b stimulates inflammation acterized by high miR-92a and miR-155 and via the nuclear factor-kappaB signaling low miR-150 expression. Leuk Res. pathway in vitro. Exp Ther Med. 2017;58:39-42. 2015;10(4): 1584-1590.
36. Wang M, Tan LP, Dijkstra MK, et al. miRNA 49. Vaisitti T, Gaudino F, Ouk S, et al. Targeting analysis in B-cell chronic lymphocytic metabolism and survival in chronic lym- leukaemia: proliferation centres character- phocytic leukemia and Richter syndrome ized by low miR-150 and high BIC/miR-155 cells by a novel NF-kappaB inhibitor. expression. J Pathol. 2008;215(1):13-20. Haematologica. 2017;102(11):1878-1889.
37. Mraz M, Chen L, Rassenti LZ, et al. miR- 50. D'Abundo L, Callegari E, Bresin A, et al. 150 influences B-cell receptor signaling in Anti-leukemic activity of microRNA-26a in chronic lymphocytic leukemia by regulating a chronic lymphocytic leukemia mouse expression of GAB1 and FOXP1. Blood. model. Oncogene. 2017;36(47):6617-6626. 2014;124(1):84-95. 51. Volinia S, Galasso M, Costinean S, et al.
38. Balatti V, Tomasello L, Rassenti LZ, et al. Reprogramming of miRNA networks in MiR-125a and MiR-34a expression predicts cancer and leukemia. Genome Res. Richter syndrome in chronic lymphocytic 2010;20(5): 589-599.
leukemia patients. Blood. 2018;132(20): 52. Venkatesh T, Suresh PS, Tsutsumi R. tRFs: 2179-2182. miRNAs in disguise. Gene. 2016;579(2):133-
39. Bayraktar R, Van Roosbroeck K, Calin GA. 138.
Cell-to-cell communication: microRNAs as 53. Garcia-Barchino MJ, Sarasquete ME, Panizo hormones. Mol Oncol. 2017;11(12):1673- C, et al. Richter transformation driven by 1686. Epstein-Barr virus reactivation during thera-
40. Fabbri M, Paone A, Calore F, et al. py-related immunosuppression in chronic MicroRNAs bind to Toll-like receptors to lymphocytic leukaemia. J Pathol. 2018;245 induce prometastatic inflammatory (1):61-73.
response. Proc Natl Acad Sci U S A. 2012; 54. Shah MY, Ferrajoli A, Sood AK, Lopez- 109(31):E2110-2116. Berestein G, Calin GA. microRNA
41. Meisgen F, Xu N, Wei T, et al. MiR-21 is up- Therapeutics in cancer - an emerging con- regulated in psoriasis and suppresses T cell cept. EBioMedicine. 2016;12:34-42.
haematologica | 2019; 104(5)
1015